HCA Fair Value
2B
The fair market value of 2BH.MU stock is 235.67 EUR. Relative to the market price of 359.7 EUR HCA Healthcare is overvalued by 34.5%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
HCA Valuation
Current 2BH.MU share ticker price is 359.7 EUR.
The fair value level of 235.67 EUR can be considered as an effective entry point for long-term investors to start investing in 2BH.MU stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 34% higher its fair value
Current price is 47% higher its minimum value
Current price is 22% higher its maximum value
Market price:
2BH.MU stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
HCA Healthcare Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
14.57
2
Median P/E over 5 years
12.21
3
Minimum P/E over 5 years
9.9
4
Earning per share (last 12 months)
21.56 USD
Maximum value
1
x
4
=
281.12 EUR
Fair value
2
x
4
=
235.67 EUR
Minimum value
3
x
4
=
191.01 EUR
HCA Healthcare Inc price metrics
25.1
Annual return (geometric mean)
38.0
Risk (standard deviation) of returns
β
0.7
Beta (volatility compared to market)